Medidata Solutions Executives to Lead Sessions at Key DIA Events in March

Puntúa la noticia :

Nota de los usuarios: - (0votos)

• Bolsa, mercados y cotizaciones
• Empresas y finanzas

Share

Tweet

elEconomista.es en Twitter

Follow @eleconomistaes

EcoTablet - ¡Gratis en App Store!

La plataforma más completa de información y servicios económicos para iPad.

• Suscribirse al boletín
• Imprimir
• Enviar
• Aumentar texto
• Reducir texto
• Haga doble click sobre una palabra para ver su signifcado
• Sudoku: Juega cada día a uno nuevo
• El tiempo: Consulta la previsión para tu ciudad

Medidata Solutions, a global provider of electronic clinical data
capture, management and reporting solutions, today announced that top
executives will present at the following industry events:

DIA 20th Annual EuroMeeting

March 3-5, 2008, Barcelona, Spain

Speaker: Graham Bunn, Vice President of Global CRO Partnerships

Session Title: "Enabling Sponsor-CRO Productivity through Global
Information Management"

Date & Time: March 4, 2008 at 4 p.m. ET

DIA´s 20th Annual EuroMeeting brings together professionals from
the biopharmaceutical industry, contract service organizations,
academic research centers and regulatory agencies to cover a variety
of topics - from regulatory issues to health economics. On the second
day of the conference, Graham will deliver a presentation on CRO
productivity focusing on global information management, changes in the
methods and roles of clinical data management and centralized project
management of global trials that draw from multiple sources of
information.

23rd Annual DIA Conference and Exhibition: Data Management in
Transition: Putting the "e" in Data Management

March 16-18, 2008, Washington DC

Speaker: Barton Cobert, Vice President Global Regulatory
Initiatives and Pharmacovigilance

Session Title: "The FDA Revitalization Act, Drug Safety and Data
Management: Great Expectations or Bleak House?"

Date & Time: March 17th, 2008 at 1:30 p.m. ET

Speaker: Keith Howells, Vice President of Development

Session Title: "Living Without a Clinical Data Management System"

Date & Time: March 18, 2008 at 3:30 p.m. ET

Speaker: Rick Piazza, Vice President of New Products

Session Title: "Sequential Adaptive Design Considerations in
Observational Studies and Registries"

Date & Time: March 18, 2008 at 3:30 p.m. ET

This year´s conference will feature expanded tracks and sessions
on data management and eClinical topics for the clinical data
management professional. In the first Medidata presentation of the
conference, Bart will review the FDA Revitalization Act to-date and
discuss implications regarding data management as well as trends in
safety data management including globalization, outsourcing and
offshoring. Keith will deliver a presentation on companies choosing to
go directly from EDC to data analysis, without the traditional
clinical data management system. During this session, attendees will
hear about real-world experiences and implications for the future. At
the same time, Rick will address the use of sequential adaptive
methodology and provide a forum for consistent application of this
strategy in Phase IV programs, observational studies and registries
with a specific discussion on the impact to data management.

For background information about Medidata executives, please visit
http://www.mdsol.com/about/team.htm.

About Medidata Solutions Worldwide

Medidata Solutions helps the world´s leading pharmaceutical,
biotechnology, medical device and research organizations maximize the
value of their clinical research investments. Innovative process
design, technology and services streamline clinical trials by
providing early visibility to reliable clinical data - the lifeblood
of every research organization. Working with companies and
institutions both large and small, Medidata Solutions helps clinical
researchers safely accelerate the process of bringing life-enhancing
treatments to market - on six continents and in more than 80
countries. Medidata Solutions brings significant value to its broad
client base with deep clinical experience and expertise in more than
20 therapeutic areas, projects in Phase I, II, III, IV, registries and
surveillance, and studies with thousands of investigators and
tens-of-thousands of subjects. For more information, please visit
www.mdsol.com.

PUBLICIDAD

- Recibe nuestros análisis Diarios sobre Divisas, Acciones y Opciones. ¡Apúntate ya! ¡Es GRATIS!

- Opere en más de 8.000 CFDs. Infórmese y obtenga su CFD Trading Guide

- Nuevos spreads en materias primas: Oro tan sólo 0,3 puntos, Plata 0,25, Petróleo 0,35

- Opera desde 2,95 € en tiempo real con Self Bank.